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SHORT COMMUNICATIONS
Screening of Genetic Risk among Relatives and the General
Public: Exploring the Spectrum of the Psychosis Prodrome
Salleh Mohd Razali", Zarina Zainan Abidin', Zaharuddin Othman^',
Mohd Azhar Mohd Yassin '^
ABSTRACT
Objective: A large percentage of subjects with self-reported psychotic-like experiences (PLE) are found in the community
and their status is unclear. The aim of the study is to detect the prevalence of non-affective psychosis and those vfith PLE among
the relatives of patients with schizophrenia and the general public.
Materials and methods: This was a two-stage procedure involving the first and second degree relatives of patients with schiz-
ophrenia and the general public. In the initial stage, the subjects were screened using a Screening Questionnaire (SQ). The posi-
tive subjects proceeded to the second stage and were assessed using the Comprehensive Assessment of At-Risk Mental State
(CAARMS), the Global Assessment of Function (GAF), Hamilton Depression Rating Scale (HDRS) and Hamilton Anxiety
Rating Scale (HARS).
Results: A total of 660 subjects equally divided between the two groups formed a final sample. In the first stage, 170 (26%)
subjects had positive scores on the SQ which was significantly higher in the general public. In the second stage, 34 (20%) cases
were found to be positive, with a higher proportion among the relatives at genetic risk. The numbers of subjects with sub-
threshold of attenuated psychotic symptoms (STAPS) (27%) and STAPS with affective symptoms (STAPSAS) (32%) detected
was higher than those at Ultra High Risk (UHR) (23%) and non-affective psychosis (18%). Although no significant difference in
the number of specific cases was detected between the general public and relatives at genetic risk, the proportion of relatives at
genetic risk steadily increased as the illness progressed to full blown psychosis.
Conclusions: Clinical assessment or re-interview following a self-report questionnaire is mandatory to detect individuals
with psychotic disorders. The prevalence of subjects with elementary PLE (sub-threshold of APS) was higher than subjects with
established psychotic symptoms such as UHR individuals. The prevalence of depression was high in pre-psychotic states before
the psychotic symptoms became prominence. The contribution of genetic factors was more prominent as the illness progresses to
frank psychosis.
KEY WORDS
attenuated psychosis, early psychosis, psychotic-like experiences, psychosis prodrome, self-report questionnaires
INTRODUCTION
The benefits of early intervention in schizophrenic psychosis
have been well-documented". Compelling evidence suggests that a
shorter duration of untreated psychosis (DUP) is associated with a
more favorable illness outcome with regards to symptomatology,
hospitalization and remission rates, relapse, social and cognitive
functioning, and response to medication and courses of treatment^".
Identification of individuals at high risk of developing a psychotic
disorder is therefore a compelling research goal. This would then
potentially prevent full-blown psychosis, minimizing symptoms or
disability and hence improving outcomes'". The 'at-risk'" period—
which is sometimes called prodromal", ultra high risk (UHR)" or
clinical high risk (CHR)*'—is defined by worsening positive and neg-
ative symptoms, and a deteriorating course of psychosocial impair-
ment culminating in the onset of frank psychosis.
Despite the growing optimism about prevention, little is under-
stood about the basic characteristics of the prodrome or about its
developmental course. There is a lack of solid, prospective data avail-
able to indicate the extent to which prodromal risk factors actually
predict schizophrenia'-'". Although prevention in this case will be sec-
ondary, the search for prodromal risk factors is currently considered
'cutting edge' from a risk research prospective"". Genetic high-risk
studies have indicated that subtle deficits can be identified long
before psychosis emerges and that these deficits can serve as predic-
tors of later schizophrenia. The premorbid phase of schizophrenia is
characterized by social and cognitive deficit; alongside subtle neuro-
logical abnormalities which long precede the first episode of psy-
chosis'".
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Figure 1. Flow chart of the screening
A few studies'^"" have reported that the majority of self-reported
psychotic-like experiences (PLE) have not been found to be associat-
ed with a psychotic disorder and will disappear over time. A systemic
review and meta-analysis found that the yearly conversion rate to a
clinical psychotic outcome in individual with sub-threshold psychotic
experiences was 3.5 times higher than for individuals without experi-
ences and there was the evidence of dose-response with severity/per-
sistence of psychotic experiences'". The onset of psychosis typically
emerges in young people, with 80% of first episodes occurring
between ages 16 to 30 years'". Current research found that individu-
als at risk of psychosis demonstrate early anxiety and mood distur-
bances, especially depression in addition to prominent functional dis-
ability" """; even depression and anxiety are often the first symptoms
to emerge in psychosis'". Yung et al'" pointed that affective distur-
bance such as depressive symptoms are frequently marked the onset
of the initial prodrome of psychosis. Depression has also been found
to be an important factor in mediating outcome in those with PLE in
the community and UHR populations'".
We implemented a two-stage procedure to detect individuals with
non-affective psychosis and at risk for psychosis among the relatives
of Malay patients with schizophrenia and compared them with the
general population. The specific objectives of this study were to
detect subjects at UHR and sub-threshold of Attenuated Psychotic
Symptoms (APS); and explored the associated affective symptoms,
especially depression and anxiety which are common in early psy-
chosis""'"
MATERIALS AND METHODS
Subjects
In this study the sample was divided into two groups of equal
size. The first group consisted of the relatives of Malay patients with
schizophrenia, while the second group was from the general popula-
tion of ethnic Malays. More than 90% of the population in the loca-
tion of the study, the north-eastern part of Peninsular Malaysia, is
Malay. Another 8% are Chinese and Indian, forming the minority
group. The sample was selected through convenience sampling. The
first and second degree relatives of patients with schizophrenia
(DSM-IV-TR)'°' from 12 to 30 years old were approached to take part
in the study when they visited the psychiatric ward during visiting
hours or accompanied psychiatric patients to the psychiatric clinic of
Hospital USM for a follow-up visit. If they agreed to take part in the
study, other family members were then contacted to arrange an inter-
view. Some of the relatives were interviewed at home with the assis-
tance of the Community Mental Health Team (CMHT). Members of
the general public within the same age group without a family history
of schizophrenia among their first and second degree relatives were
also selected through the same sampling method. They were chosen
from among the patients' neighbors during community visits, hospital
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Figure 2. The SQ scores of relatives at genetic risk vs. general
public
visitors, pedestrians, job-seekers, general workers, and school and
college students. The study protocol had been approved by The
Ethical Committee (Human), Universiti Sains Malaysia (USM).
Exclusion criteria
Subjects were excluded if they:
a. declined to sign informed consent;
b.had been treated for psychotic illness or were being treated
with antipsychotic drugs;
chad co-morbid substance abuse, mental retardation, organic
mental disorders or other related conditions.
Assessment
Initial Screening
The preliminary (first stage) screening was conducted by research
assistants (RA). All the selected subjects were screened using a
Screening Questionnaire (SQ). The SQ, which was modified from the
SIPS screen^", consisted of 10 items of positive symptoms requiring a
dichotomous 'yes' or 'no' response. The SQ was translated into Malay
and had been validated previously. The sensitivity and specificity of
the SQ at the cut-off point of 2 was 77.5% and 93.5% respectively^ '^.
Those subjeets who scored 2 and above would proceed to the second
stage.
Second Stage Screening
The second stage assessment was conducted by the research psy-
chiatrists using the Comprehensive Assessment of At-Risk Mental
State (CAARMS)"'. The Hamilton Depression Rating Scale
(HDRS)"' and Hamilton Anxiety Rating Scale (HARS)'"' were admin-
istered to evaluate the severity of depression and anxiety respective-
ly. The screening process and assessment are summarized in a flow
chart (Eigure 1). The overall level of function was assessed using the
DSM-IV-TR Global Assessment of Function (GAF) scale^"'. If posi-
tive symptoms were detected (disorders of thought content, perceptu-
al abnormalities and disorganized speech), further exploration was
required to assess the severity, frequency and duration of symptoms.
Further assessment was conducted with the schizotypal personality
disorder (PD) check list™' for second degree relatives and the general
public.
The positive subjects were classified according to 5 main cate-
gories;
(i) Full-blown non-affective psychosis (schizophreniform disor-
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der/schizophrenia) if the subjects reached or exceeded the
psychotic threshold as defined in CAARMS"'
Two of the three operationally defined UHR sub-groups^" were
categorized as:
(ii) Brief limited intermittent psyehotic symptoms (BLIPS) or
attenuated psychotic symptoms (APS).
The primary degree relatives and other subjects with schizotypal
PD who had least 30% drop in GAF score from premorbid level, sus-
tained for a month were elassified as the third subgroup of UHR^"
(iii) Vulnerable group (VG).
We created another category (sub-threshold of APS) for lower
risk subjeets in which the positive symptoms were less severe (sub-
threshold intensity) or present in low frequency (sub-threshold fre-
quency), but fulfilled other criteria of APS; such as the symptoms
present in past year and for not longer than 5 years as defined in
CAARMS"'.
(iv) Sub-threshold of APS (STAPS).
The operational criteria of STAPS are as follows:
Sub-threshold intensity: Severity scale score of 2 on disorder of
thought content subscale, 2 on perceptual abnormalities subscale
and/or 3 on disorganized speech subscales of the CAARMS"' Plus
: Frequency scale score of 3-6 on the dis-
order of thought content, perceptual abnormalities and/or disorga-
nized speech subscales of the CAARMS"' for at least a week or fre-
quency scale score of 2 on disorders of thought content, perceptual
abnormalities and disorganized speech subscales of the CAARMS"'
on more than 2 occasions
Sub-threshold frequency: Severity of scale score of 6 on disorder
of thought content subscale, 5- 6 on perceptual abnormalities sub-
scale and/or 6 on disorganized speech subscales of the CAARMS"'
Plus
: Frequency scale score of 2 on the disor-
der of thought eontent, perceptual abnormalities and/or disorganized
speech subscales of the CAARMS"'
Subjects with STAPS in addition to positive HDRS^"' scores and/
or HARS^* scores, they were classified separately as:
(v) STAPS with affective symptoms (STAPSAS).
Statistical analysis
Statistical analyses were performed using the Statistical Package
for the Social Sciences, version 16.0 (SPSS Inc., IL., USA). The
Mann-Whitney U-test was used to assess continuous data and cate-
gorical data were analyzed using the chi-square test since the data
were non-parametric. Results were eonsidered statistically significant
at p< 0.05.
RESULTS
Initial screening
Finally, 660 subjects, equally divided between the two groups,
entered the initial screening. Out of 330 relatives at genetic risk, 239
(72.4 %) were first degree relatives, while 91 (27.6 %) were second
degree relatives. The mean age of the relatives at genetic risk was
19.35 (SD 5.2) years, while for the general public the mean age was
21.31 (SD 3.9) years. There were no significant differences in age,
sex and highest educational status between the subjects in both
groups. There were 170 subjects (25.8%) from both groups who had
positive scores on the SQ (scored 2 and above) and proceeded to the
second stage of screening. Of these, 110 were from the general public
and 60 were relatives at genetic risk.
The SQ scores and socio-demographic variables
The mean SQ scores for both groups was 1.015 (SD 1.49). The
mean SQ seores for the general public and relatives at genetic risk
were 1.285 (SD 1.63) and 0.746 (SD 1.27) respectively. The mean
score for the general public was significantly higher than that for rel-
atives at genetic risk (Z = -4.721, p < 0.001). The distributions of the
SQ scores for both groups are displayed in Figure 2. There were no
significant differences in age, gender and highest level of education
between those who scored positively and negatively on the SQ.
However, the numbers of the general public who scored positively on
the SQ (33.3%) were significantly higher than the relatives at genetic
risk (18.2%) (j;^= 19.808, df= 1, p < 0.001) (Table 1).
Second stage screening
Out of 170 subjects who proceeded to the seeond stage, 34 (20%)
were found to be positive. The distribution of the detected cases is
shown in Table 2. The overall prevalence of STAPS and STAPSAS
(3%) was higher than Ultra High Risk (UHR) (1.2%) and non-affec-
tive psychosis (0.91%). Twenty (59%) subjects had elementary PLE
(9 STAPS and 11 STAPSAS) as compared to 8 subjeets at UHR
(23%) and 6 cases of schizophrenia/schizophreniform disorder
(18%). Among 8 subjects at UHR, 7 were APS and onlyl BLIPS. No
cases of VG were detected. A few cases of major depression without
psychosis and 2 cases of major depression with psychosis were
detected, but they were excluded from the study. In the second stage,
21 subjects detected were relatives at genetic risk; the number of
detected cases was significantly higher among relatives at genetic
risk (35%) as compared with the general public (11.8%) ( x^ =
13.040, df = 1, p < 0.001). Although no significant difference in the
number of specific cases was detected between the general public and
relatives at genetic risk, the prevalence of relatives at genetic risk
steadily increased as the illness progressed to frank psyehosis.
DISCUSSION
The results show a remarkable difference between the SQ scores
and clinical assessment in the second stage. However, after the inter-
view in the second stage, the number of true positive cases dropped
drastically in both groups. Approximately 33.3% of the subjects from
the general public and 18.2% of the relatives at genetic risk had psy-
chotic symptoms based on the SQ scores; this dropped to 3.9% and
6.4% respectively after the interview was conducted using
CAARMS"'. The drop in the number of positive cases was higher
among the general public (29.4%) as compared with relatives at
genetic risk (11.8%). The study also found a significant difference
between the SQ scores for the general public and those for relatives
at genetic risk. However, the scores were not influenced by the age,
gender and educational status of the subjects. One explanation for the
differenee is that at-risk subjects without a psychotic-level conviction
of their experiences rather overestimate their symptoms in the same
way as people in the general population. In contrast, psychotic or
schizophrenia patients may underestimate their experiences because
of the unrealistic natures of their experiences, beliefs, and so on-"" .
A few other studies have reported a similar discrepancy between
self-reported PLE and the prevalence of psychosis, although differ-
ence methodology was used. In other words, prevalence figures for
self-reported PLE are high, while the frequency of individuals fulfill-
ing the criteria for schizophrenia or non-affective psychosis is low.
Ochoa et al"' found that 11.8% of the general population reported
psychotic symptoms, but the prevalence of psychotic disorders was
between 0.85 to 2.37%. In The National Comorbidity Study,
Kendler-"' found that 28.4% were screened positive for any type of
psychotic experience; whereas the prevalence of broadly defined psy-
chosis was only 0.7%. Recently Grano et al-"" found a significant dif-
ference between psychosis risk scores based on self-report versus
interviews with adolescents.
We found that the prevalence of detected eases was higher among
the relatives at genetic risk (63.6%) than in the general population
(39.4%). The overall prevalence was higher in STAPS and STAPSAS
(3%) as compared with UHR (1.2%) and non-affective psychosis
(0.91%). The strong hnk to genetic factors is also supported by the find-
ing that the proportion of relatives at genetic risk increased as the illness
progressed to full-blown psychosis; i.e. from 60% (STAPS/ STAPSAS)
to 62.5% (UHR), and to 62.5% and 66.7% (schizophrenia/schizophreni-
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Table 1. The relationship between positive SQ scores with age,
gender, genetic status and educational status
Table 2. The distribution of detected cases in the second stage of
screening
Variables Positive SQ
n = 170 (n%)
X (at) IX p - value
1. Age (year)
Mean (SD)
Female
Male
2. Gender
Female
Male
3. Genetic Status
Public
Genetic risk
4. Educatinal Status
Primary School
Lower Secondary
Upper Secondary
College / Diploma
University
Professional degree
*Mann-Whitney Test
20.08(5.21)
20.46 (4.45)
48(21.8)
122 (27.7)
110(33.3)
60(18.2)
7(20)
26 (22.4)
66 (27.5)
58 (28.7)
12(19.4)
1(3)
-0.167
2.678(1)
19.808(1)
4.004 (5)
0.867*
0.102
< 0.001
0.549
form disorders). The prevalence of schizophrenia/schizophreniform dis-
orders among relatives at genetic risk was 1.2%, which is much lower
than expected. About 8% of siblings and 12% of cbildren of schizo-
phrenic individuals will develop schizophrenia compared to approxi-
mately 1% in the general population'"'. The lower result found in this
study is probably due to the weakness in sampling and narrow age
range of the study population (12-30 years old). The prevalence of sub-
jects with PLE or sub-clinical psychosis (STAPS, STAPSAS and UHR)
was 4.2%; it was lower than tbe median prevalence of about 7% as
reported in the previous meta-analysis from the cohort study'" and
among adolescents aged 13 to 18 years'-'. The lower prevalence found
in this study is partly due to tbe differences in screening procedure and
population sampling, and low sensitivity of the screening questionnaires
(SQ).
Tbe prevalence of STAPSAS (1.7%) was sligbtly higher than
STAPS (1.4%) or 55% of tbe subjects with sub-threshold of APS had
associated depression and/or anxiety. This showed that depression
was common in the pre-psychotic states, such as in sub-threshold of
APS before tbe psycbotic symptoms was well-established.
Depression has been found to be a significant predictor of psycbosis
in tbe UHR groups'" and an important factor in mediating outcome in
those with PLE in botb community and UHR populations'". It also
associated with increased risk of transition to psychotic disorder in
the UHR group. Yung et al"^ also stressed tbe importance of assess-
ment of depression in those with PLE and consider the need for treat-
ment of the co-morbid depressive syndrome, wbicb may reduce the
risk of worsening of PLE and transition to psychotic disorder.
One hundred and seventy (26%) of the sample screened positive
on the SQ, but only 14 (8.2%) of them were positive (full blown psy-
chosis and UHR) in the second stage. This shows tbat the sensitivity
of the SQ was lower than 77.5% as found in the previous validation
study'-'. It is hard to explain but probably the study subjects tend to
minimize or hidden their symptoms because they knew that they were
being screened for mental illness. In Asian culture, the stigma
towards people with severe mental illness (SMI) was strong; the pub-
lic tend looks down on them and their families'". Other possibilities
that the subjects did not really understand or interpret differently the
self-report questionnaires (SQ); especially majority of them were in
tbe young age and could not differentiate between psycbotic symp-
toms and normal experiences. Thus, this study support the need of
clinical assessment or re-interview following a self-report question-
naire in detecting individuals with psychotic disorders among the
general population.
There are pro and con regarding screening of psychosis in the
general population. The aim of the screening is to start early inter-
vention so that those detected (at-risk subjects) do not progress to full
Diagnoses Relatives at General public Total (n^
genetic risk ( n = I 3 ) (n = 34)
(n = 21)
1. Schizophrenia/
Schizophreniform disorders
2. BLIPS/APS
3. STARS
4. STAPSAS
4
5
5
7
2
3
4
4
6(18)
8(23)
9(27)
11(32)
blown psychosis. In a systemic review and meta-analysis. Van Os et
al*" found that approximately 75-90% of subjects with subclinical or
sub-threshold PLE is transitory and disappeared over time. Thus, the
subjects such as STAPS and STAPSAS do not require treatment in
view of low conversion risk. The controversies arise for subjects at
UHR; especially witb tbe recent finding that the transition rate to
psychosis had declined to 19% at the 18 months follow-up"' and to
16% at the two years follow-up", which are unfavorable for pharma-
cological intervention. A recent study'", which found that majority of
the at-risk subjects who did not transition to full-blown psychosis
over 2 years were improved with fewer symptoms and better func-
tioning, indicating that antipsychotics treatment generally is also not
required. This is in accordance with de Koning et al''" conclusion in
their review that at present, the data concerning the benefits and risks
do not justify prodromal intervention as a standard clinical practice.
This supported by tbe finding that the prodromal symptoms are
non-specific'"" and we are not sure which individuals would benefit
from antipsychotic treatments; otherwise they were unnecessarily
treated with antipsycbotics and might develop side-effects, as well as
being labeled as mentally ill. There are also suggestions that contrary
to expectation the antipsychotic drugs may not be able to prevent the
transfer to psychosis"". The treatment with antipsychotics drugs may
be palliative and just delay the onset of psychotic disorders; the rate
of conversion and exacerbation of prodromal symptoms is increased
after discontinuing antipsychotic treatment'". The finding that the
transition to psychosis is at greater risk if the subjects are help-seek-
ing who meet UHR or prodromal criteria is another setback for public
screening"". However, a small group of individual at-risk who dete-
riorated rapidly, dangerous to the others, had aggressive behavior and
severe suicidal risk is indicated for antipsycbotic treatmenf"'. Those
detected with schizopbreniform disorder/schizophrenia were most
benefited from tbe screening program because early antipsychotic
treatment will shorten the DUP and improved prognosis'".
Nevertheless, the present study also has several limitations, such
as a small sample size, the use of convenience sampling (selecting
subjects who happened to be available), and the fact that the two
study groups were not matched. These methodological weaknesses
would exclude some positive cases and result in low prevalence.
Universal sampling is better for a prevalence study and tbe important
parameters such as age, gender and educational status between the
two groups should be controlled in order to get a homogeneous sam-
pie.
CONCLUSION
Clinical assessment or re-interview following a self-report ques-
tionnaire is mandatory to detect individuals with psychotic disorders
in general population. The prevalence of depression was high in pre-
psychotic states, such as in sub-tbreshold of APS before the psychot-
ic symptoms was prominence. The status of individuals with sub-
threshold of APS remains uncertain and needs further study; especial-
ly the prognostic differences between those with affective symptoms
(:STAPSAS) and without affective symptoms (STAPS). It would be
interesting to followed-up them in the long term and assess the rate
of transition to UHR and psychotic disorders. The prevalence of sub-
jects with elementary PLE such as STAPS and STAPAS was higher
than subjects with established psychotic symptoms such as UHR
individuals. The contribution of genetic factors cannot be taken light-
ly since the proportion of relatives at genetic risk increased steadily
as the illness progressed to full-blown psychosis.
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